Form D · Biotechnology
BioAegis Therapeutics, Inc.
Morristown, NJ · CIK 0001546604
Offering snapshot reported May 11, 2022 · SEC filing
- Reported sold
- $21.8M Offering amount: $21.8M
- Investors reported
- 27 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 23, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 11, 2022 | Initial | $21,770,592 | No comparison | 27 | SEC filing |
| Oct 7, 2020 | Amendment | $7,000,000 | $2,000,000vs Jun 17, 2020 | 147 | SEC filing |
| Jun 17, 2020 | Initial | $5,000,000 | No comparison | 122 | SEC filing |
| Sep 26, 2018 | Initial | $4,083,293 | No comparison | 10 | SEC filing |
| Mar 14, 2016 | Initial | $1,500,000 | No comparison | 1 | SEC filing |
| Apr 17, 2015 | Amendment | $8,036,412 | $4,304,000vs Feb 7, 2014 | 77 | SEC filing |
| Feb 7, 2014 | Amendment | $3,732,412 | $590,000vs Feb 8, 2013 | 48 | SEC filing |
| Feb 8, 2013 | Amendment | $3,142,412 | $2,645,000vs Apr 11, 2012 | 42 | SEC filing |
| Apr 11, 2012 | Initial | $497,412 | No comparison | 13 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-445247
Source: Form D, filed May 11, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Valerie Ceva | Director, Executive |
| Steven Cordovano | Executive |
| Steve Cordovano | Executive |
| Mark Di Nubile | Director, Executive |
| Susan Levinson | Director, Executive |
| Thomas Stossel | Director, Executive |
| John Stossel | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
6 East Cove Lane
Morristown, NJ, 07960
Morristown, NJ, 07960